Stemtech Corporation

STEK

US85859W1027

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:59:21 2024-04-16 pm EDT			5-day change	1st Jan Change
0.0716 ^USD	+0.21%		-10.50%	+120.31%

Jan. 31	Stemtech Corporation Expands Global Reach with New License Agreement in Africa	CI
2023	Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Stemtech Cororation Announces Life Factor Research Obtains First Production Contract with New Customer

December 22, 2022 at 01:20 pm EST

Stemtech Corporation has acquired its first contract to produce a while label product for a new client.

Latest news about Stemtech Corporation

Stemtech Corporation Expands Global Reach with New License Agreement in Africa	Jan. 31	CI
Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Dec. 01	CI
Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-22	CI
Stemtech Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Stemtech Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-11	CI
Stemtech Corporation Auditor Raises 'Going Concern' Doubt	23-05-10	CI
Stemtech Corporation completed the acquisition of Life Factor Research for $7.9 million.	23-03-30	CI
Stemtech Corporation announced that it expects to receive $6.16 million in funding from Leviston Resources LLC	23-03-26	CI
Stemtech Corporation Announces Additional Expansion of International Markets	23-02-02	CI
Stemtech Corporation Appoints Margie and Mike Mares to Field Advisory Board	23-01-10	CI
Stemtech Cororation Announces Life Factor Research Obtains First Production Contract with New Customer	22-12-22	CI
Stemtech Corporation Announces Introduction of Cellectone Rapid Renew Stem Cell Peptide Night Cream	22-12-06	CI
Stemtech Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-23	CI
Stemtech Corporation Announces Creation of New Stem Cell Skincare Products	22-09-19	CI
Stemtech Corporation Announces Professor Dr. Bankole Johnson Joins Their Life Sciences Advisory Board	22-09-06	CI
Stemtech Corporation entered into a letter of intent to acquire Life Factor Research.	22-08-28	CI
Stemtech Corporation Announces Orastem Trademark Registration in Mexico and Introduces New Travel Size	22-08-23	CI
Stemtech Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-23	CI
Globe Net Wireless Corp. has Changed its Ticker to STEK from GNTW	22-04-14	CI
Globe Net Wireless Corp has Changed its Name to STEMTECH CORPORATION	22-04-14	CI
Globe Net Wireless Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-01	CI
Globe Net Wireless Corp. Auditor Raises 'Going Concern' Doubt	22-03-31	CI
Globe Net Wireless Corp. Changes Year End	21-11-12	CI
Stemtech Corporation Announces Appointment of John W. Meyer to Role of President and COO	21-10-19	CI
Stemtech Corporation Announces Appointment of Two Additional Board Members	21-10-06	CI

Stemtech Corporation is a global network marketing company that develops science-based products, which support wellness by helping the body maintain healthy stem cell physiology, also known as stem cell enhancers. The Company is also known as Stem Cell Nutrition Company. The Company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood and migrate them into tissues, where they can perform their daily function of renewal for optimal health. These products are marketed internationally by the Companies subsidiaries and through independent distributors. The Company markets its products under various brands, which include RCM System, stemrelease3, Stemflo MigraStem, OraStem (Oral Health Care), and D-Fuze (Electromagnetic Frequency blocker). It also introduced a skincare product, Cellect One Rapid Renew Stem Cell Peptide Night Cream. Its segments include North America, Latin America and Asia.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Biopharmaceuticals

	1st Jan change	Capi.
STEMTECH CORPORATION	+120.31%	8.34M
CSL LIMITED	-4.17%	86.99B
SAMSUNG BIOLOGICS CO.,LTD.	+4.34%	40.68B
BIOGEN INC.	-24.59%	28.61B
UCB	+51.27%	24.1B
BIOMARIN PHARMACEUTICAL INC.	-5.76%	17.37B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-32.11%	13.72B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-5.10%	12.49B
INCYTE CORPORATION	-15.24%	12B
SWEDISH ORPHAN BIOVITRUM AB	-3.22%	7.94B